We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

Delisted

FRTX was delisted on the 18th of December, 2023.

84 hedge funds and large institutions have $130M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $4.25M | Put options by funds: $1.71M

Holders
84
Holders Change
+84
Holders Change %
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
84
Increased
Reduced
Closed
Calls
$4.25M
Puts
$1.71M
Net Calls
+$2.54M
Net Calls Change
+$2.54M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$23.7M +$26.6M +2,400 New
AI
2
Ariel Investments
Illinois
$16.1M +$18.1M +1,630 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$14.7M +$16.5M +1,488 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$13.6M +$15.3M +1,384 New
BFA
5
BlackRock Fund Advisors
California
$8.46M +$9.5M +858 New
BIT
6
BlackRock Institutional Trust
California
$7.61M +$8.55M +772 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.9M +$7.74M +699 New
LM
8
Litespeed Management
New York
$4.35M +$4.89M +441 New
WC
9
Wexford Capital
Florida
$4.15M +$4.66M +421 New
State Street
10
State Street
Massachusetts
$3.94M +$4.43M +400 New
Northern Trust
11
Northern Trust
Illinois
$3.35M +$3.76M +339 New
TC
12
TFS Capital
Pennsylvania
$1.32M +$1.48M +134 New
SAIG
13
Semper Augustus Investments Group
Colorado
$1.28M +$1.44M +130 New
ISL
14
Ingalls & Snyder LLC
New York
$1.2M +$1.34M +121 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$1.03M +$1.15M +104 New
TCIM
16
TIAA CREF Investment Management
New York
$1.02M +$1.14M +103 New
DA
17
DSC Advisors
Illinois
$942K +$1.06M +96 New
Invesco
18
Invesco
Georgia
$916K +$1.03M +93 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$890K +$997K +90 New
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$770K +$864K +78 New
CS
21
Central Securities
New York
$714K +$798K +72 New
CS
22
Credit Suisse
Switzerland
$668K +$753K +68 New
BIM
23
BlackRock Investment Management
Delaware
$654K +$731K +66 New
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$637K +$720K +65 New
Charles Schwab
25
Charles Schwab
California
$624K +$676K +61 New

FRTX Hedge Fund Activity: Q2 2013 in Review

84 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2013, worth a combined $130M.

Buyers outnumbered sellers: 84 funds opened new FRTX positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $130M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 84 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.